Alasdair Coles, Alastair Compston, V Wee Yong, Catherine Lubetzki, Hans Lassmann, Brian Weinshenker, Steve Vucic

Gebundenes Buch

McAlpine's Multiple Sclerosis

Beschreibung

For more than 70 years, McAlpine's Multiple Sclerosis has been the gold standard textbook on the science and clinical practice of MS. The 5th Edition of this classic, landmark text reflects recent advances in this complex field, bringing you up to date with current information on genetics, epidemiology, clinical neurology, pathogenesis, and management of this common neurological disease. Easy to read and abundantly illustrated, this updated reference is a must-have resource for neurologists, neuropathologists, neurophysiologists, researchers, PM&R specialists, and others who can benefit from authoritative, comprehensive coverage of both scientific and clinical aspects of MS. * Discusses recent advances in both diagnosis and management, including improved understanding of MS in childhood and the elderly, anti-MOG disease, treatments of progressive MS, remyelination and neuroprotective therapies, and more * Offers authoritative reviews of the current literature, placed in historical context * Features more than 550 high-quality illustrations clarifying important scientific and clinical concepts * Provides the most authoritative and comprehensive history of the understanding of the disease * Uses a remarkably clear presentation to make complicated data easier to understand * An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date

Autor

Alasdair Coles, Ph.D. is a Professor of Neuroimmunology in the Division of Clinical Neurosciences at the University of Cambridge. Has been doing MS research in Cambridge since 1994. He is also a consultant neurologist. With Alastair Compston, he was very involved in the development of alemtuzumab as a treatment of MS. He is employed as a senior lecturer by Cambridge University and has a small research team managing clinical trials and doing human immunological laboratory work. He does clinical work for two days a week as a consultant neurologist at Addenbrooke's and Peterborough Hospitals, is one of the medical advisers to the Multiple Sclerosis Society of the UK, and advises several pharmaceutical companies.

Produktdetails

• Verlag: Elsevier Health Sciences
• 5th edition
• Seitenzahl: 1000
• Erscheinungstermin: 2. März 2026
• Englisch
• Gewicht: 449g
• ISBN-13: 9780323936347
• ISBN-10: 0323936342
• Artikelnr.: 75166071